Potential of longitudinal data from single site and multi-center clinical trials for AI-research

Prof. Dr. Hans-Christoph Becker from Stanford University, a long-standing user of mint Lesion™, shares his experience of using the software in this brief interview. He talks about the reaction he received when sharing the mint report for the first time, how patients benefit from the longitudinal overview of disease, and his plans to use the structured data for AI research.

Click here or on the image above to watch the full video on YouTube.

Related Resources

Related Resources

University Hospital Jena: Next-level Workflow Optimization in Clinical Trials

How to set up a well-running clinical trial center that can handle up to 40 trials at once has been successfully demonstrated by Laura Graziani, study…

The benefits of structured oncologic reporting with mint Lesion™

Dr. Damiano Caruso of Sapienza Universita di Roma recounts how he got to know mint Lesion™ at a workshop hosted by the ESOI. Among other workstations,…

mint Lesion™ 3.8. Release: What’s New?

The recent 3.8 release brings with it a multitude of new features and refinements that further facilitate reporting, interdisciplinary collaboration,…